Anthony Wilson Peck (1933-)

The folder contains papers, also 2 audio tapes, also photocopy of typed unpublished account of WF's research and development by Miles Weatherall (part), and a CV with a list of his published works. The interview refers to: * his education and influence of Cyril Keele, Samson Wright and Franz Hobbiger. * the company in the early-sixties to 1994 when he retired, early use of personal computers, work with RTP, drug testing. * drugs - Benzylapiperazine, amphetamines, anti-epilepsy, Prostacyclin, Tracium, Lamotrigine, Wellbutrin, bupropion. The folders also contain copies of papers by Peck on: * Lamotrigine * WF involement in Clinical Trials in Eastern Europe 1980-1990 * Franz Hobbiger Obituary * Acrivastine (BW825C) a new Antihistamine * Triprolidine, Clemastine * Tricyclic Antidepressant Drugs, Bupropion, Nomifensine, Dexamphetamine, Diazepam and 1-Benzylpiperazine.

2 audiocassettes (3 hour)

Copyright was assigned to the Wellcome Trust for all material created or commissioned by the Wellcome Foundation, its successors and associated companies. The copyright in third party material (ie material not created by WF such as letters and publications from external sources, magazine articles, newspaper cuttings etc) is assumed to remain with the creator or his/her heirs. Where third party material exists, this has been noted at item level.

This item is restricted. You will need to complete a Restricted Access form agreeing to anonymise personal data before you will be allowed to view this item. Please see our Access Policy for more details. Restricted until 1 January 2053.